These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1653793)
41. Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats. Richer C; Doussau MP; Giudicelli JF J Cardiovasc Pharmacol; 1986; 8(2):346-57. PubMed ID: 2422474 [TBL] [Abstract][Full Text] [Related]
42. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498). Unger T; Moursi M; Ganten D; Hermann K; Lang RE J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465 [TBL] [Abstract][Full Text] [Related]
44. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855 [TBL] [Abstract][Full Text] [Related]
45. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Matrougui K; Lévy BI; Henrion D Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779 [TBL] [Abstract][Full Text] [Related]
46. Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats. Wang H; Delaney KH; Kwiecien JM; Smeda JS; Lee RM Clin Invest Med; 1997 Oct; 20(5):327-38. PubMed ID: 9336658 [TBL] [Abstract][Full Text] [Related]
47. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model. Ledingham JM; Laverty R Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439 [TBL] [Abstract][Full Text] [Related]
48. Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats. Harrap SB; Mirakian C; Datodi SR; Lever AF Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):125-7. PubMed ID: 8039264 [TBL] [Abstract][Full Text] [Related]
49. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Rizzoni D; Castellano M; Porteri E; Bettoni G; Muiesan ML; Cinelli A; Rosei EA Hypertension; 1995 Jul; 26(1):118-23. PubMed ID: 7607714 [TBL] [Abstract][Full Text] [Related]
50. Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat. Hodge G; Makarious MM; Charlesworth JA; Duggan KA Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):460-2. PubMed ID: 9171960 [TBL] [Abstract][Full Text] [Related]
51. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats. Naelten G; Liu KL; Chapuis B; Lo M Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554 [TBL] [Abstract][Full Text] [Related]
52. Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat. Scalbert E; Abdon D; Devissaguet M; Juggi JS Can J Cardiol; 1992 May; 8(4):381-6. PubMed ID: 1617521 [TBL] [Abstract][Full Text] [Related]
53. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Rizzoni D; Castellano M; Porteri E; Bettoni G; Muiesan ML; Cinelli A; Zulli R; Rosei EA Am J Hypertens; 1997 Sep; 10(9 Pt 1):1034-43. PubMed ID: 9324110 [TBL] [Abstract][Full Text] [Related]
54. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity. Duggan KA; Hodge G; Makarious MM; Charlesworth JA Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674 [TBL] [Abstract][Full Text] [Related]
55. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386 [TBL] [Abstract][Full Text] [Related]
56. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083 [TBL] [Abstract][Full Text] [Related]
57. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951 [TBL] [Abstract][Full Text] [Related]
58. The blood vessel as a target organ in hypertension: protective effect of perindopril. Plante GE Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036 [TBL] [Abstract][Full Text] [Related]
60. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels. Black MJ; Campbell JH; Campbell GR Am J Cardiol; 1993 Jun; 71(17):17E-21E. PubMed ID: 8328362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]